Table 3 Sequences of primers used in this study
Gene Name | Sequence |
|---|---|
GAPDH | Forward: 5′-ACCCAGAAGACTGTGGATGG-3′ Reverse: 5′-ACACATTGGGGGTAGGAACA-3’ |
PPAR-α | Forward: 5’-CCTCAGGGTACCACTACGGAGT-3′ Reverse: 5′-GCCGAATAGTTCGCCGAA-3’ |
PPAR-γ | Forward: 5’-AGGCCGAGAAGGAGAAGCTGTTG − 3′ Reverse: 5′-TGGCCACCTCTTTGCTGTGCTC-3’ |
CYP7A1 | Forward: 5’-AGCAACTAAACAACCTGCCAGTACTA-3′ Reverse: 5′-GTCCGGATATTCAAGGATGCA-3’ |
CPT1 | Forward: 5’-AAAGATCAATCGGACCCTAGACA-3′ Reverse: 5′-CAGCGAGTAGCGCATAGTCA − 3’ |
C/EBP-α | Forward: 5’-TGGACAAGAACAGCAACGAGTAC − 3′ Reverse: 5′- GCAGTTGCCCATGGCCTTGAC-3’ |
SOD1 | Forward: 5’-AGGTCGGTGTGAACGGATTTG-3′ Reverse: 5′-GGGGTCGTTGATGGCAACA-3’ |
SOD2 | Forward: 5’-CAGACCTGCCTTACGACTATGG-3′ Reverse: 5′-CCACCATGTTTCTTAGAGTGAGG-3’ |
LPL | Forward: 5’-AGGGCTCTGCCTGAGTTGTA-3′ Reverse: 5′-AGAAATCTCGAAGGCCTGGT-3’ |
CAT | Forward: 5’-GGAGGCGGGAACCCAATAG-3′ Reverse: 5′-GTGTGCCATCTCGTCAGTGAA-3’ |
GSH-Px | Forward: 5’-CCACCGTGTATGCCTTCTCC-3′ Reverse: 5′-AGAGAGACGCGACATTCTCAAT-3’ |
GSH1 | Forward: 5’-GGGTGAAGCACAAGAAAGAAGG-3′ Reverse: 5′-TTGGCTGAGGAGCGAAGA-3’ |